Cost-effectiveness of moderate-to-severe psoriasis treatment.
about
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectiveThe cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.Psoriasis causes significant economic burden to patients.The cost of biologics for psoriasis is increasingAdherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature.The costs of psoriasis medications.Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil.A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.Cost effectiveness of biologic therapies for plaque psoriasis.Perceptions of U.S. Dermatology Residency Program Directors Regarding the Adequacy of Phototherapy Training during Residency.1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment.Biomedical and Market Issues Surrounding the Advent of BiosimilarsTrends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg.Concurrent use of methotrexate and acitretin revisited.Cost effectiveness of moderate to severe psoriasis therapy with etanercept and ustekinumab in the United States.Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease.
P2860
Q26747639-531D5C51-4606-4438-88A0-BF9AFDF9E98DQ33646654-2D6BBB28-D849-4F3B-B893-47014845303FQ33785034-EFB47B38-2A36-4E34-AB2A-3F56E27E9001Q34973745-3C66132A-68A6-403B-ACC0-C855C935FE4DQ37427086-348A48BA-D21F-4D2A-A0FF-A61BEDADB0EAQ37468355-8CCB272E-146F-45AB-B842-6A94D46413DEQ37628279-E9C6978B-E8F8-49B4-A039-AD1FE468F890Q37898704-7EA22C4E-9BE0-4328-845A-9800D37DACE2Q37980484-D296D120-07F7-4CE4-91C2-B6AAA77544B3Q38108567-D040200B-63C0-4DEF-B354-0AF8C612538FQ38600589-E4DDA787-9098-4EF6-9594-90EA0C48E59CQ40190310-0DC6CE77-5033-4CE7-96ED-97A07C739B88Q42382034-18B2F13A-58EF-46F1-9B6E-14365D2529DEQ44549092-460B4413-01E1-4313-A69D-1CC627F7555CQ46754887-13961480-7D8D-4FE5-BADA-743F054B89E7Q46945261-C6EABC0F-C554-4579-B11A-698D29B5FBCCQ50074891-02598625-CFD7-41E1-A87F-8D2A6F6D1C18
P2860
Cost-effectiveness of moderate-to-severe psoriasis treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@ast
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@en
type
label
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@ast
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@en
prefLabel
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@ast
Cost-effectiveness of moderate-to-severe psoriasis treatment.
@en
P2860
P356
P1476
Cost-effectiveness of moderate-to-severe psoriasis treatment
@en
P2093
Drew W Miller
P2860
P304
P356
10.1517/14656566.7.2.157
P407
P577
2006-02-01T00:00:00Z